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Background
Many cancers are associated with functional mutations
which can be readily identified using new DNA sequen-
cing methods. Sequence information is used for the gen-
eration of personalized cancer vaccines with promising
clinical benefit. Intelligent ways to select the relevant,
tumor-specific protein-coding mutations are applied to
filter the large number of identified mutations to a man-
ageable number. Besides, there is an increasing data
pool of both germline and somatic mutations, for the
latter frequently even with attached information on the
tissue and histology. Although the use of a patient-spe-
cific antigen sequence represents a very promising basis
for treatment and immune monitoring its identification
and translation to corresponding reagents is still slow,
laborious and expensive. Intelligently designed peptide
libraries that cover sequence variability based on known
antigen mutations may serve as easily accessible tools
with broad exertion across patient cohorts in cases
where the individual sequence is not readily available.
Methods
Pools of antigen spanning peptides are increasingly used
for T cell stimulation in T cell assays and even for
immunotherapeutic treatment. Underlying peptide
libraries are well suited for presenting sequence diver-
sity. However, the currently used libraries consist of
overlapping peptides of wild-type antigen sequences. We
recently introduced a concept for diversity enhancement
to the design of peptide pools covering immune relevant
HIV antigens for which diversity between individual
viruses poses many challenges. Exemplary, for the ENV
protein an increase in sequence coverage from 10% to
34% could be achieved. In order to keep the number of
individual peptides within peptide pools of tumor anti-
gens at a controllable level, a complex filtering of
sequence data is applied to enrich the library with pep-
tides carrying different tumor-specific and ideally func-
tionally relevant mutations.
Our aim is to generate peptide libraries for specific anti-
gens, which represent a generic cancer mutanome applic-
able to a large number of individual patients, based on
available databases as the catalogue of somatic mutations
in cancer (COSMIC) and epitope information from the
immune epitope database (IEDB) as well as prediction
algorithms.
Results
A library type can contain the full length sequence of the
antigen enriched by peptides representing overlapping
scans for relevant mutations. Alternatively, known or pre-
dicted epitopes can be selected and the mutated epitopes
added. However, mutations can lead to the creation of
new epitopes and mutated epitopes can escape from
MHC-binding. Epitope prediction can help to account for
these effects. We’ve built a pipeline for the efficient gen-
eration of such libraries which will be presented here.
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